CD44 is a biomarker associated with human prostate cancer radiation sensitivity
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD44 is a biomarker associated with human prostate cancer radiation sensitivity
Authors
Keywords
-
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume 29, Issue 1, Pages 1-9
Publisher
Springer Nature
Online
2011-09-27
DOI
10.1007/s10585-011-9423-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer
- (2011) Xiaomeng Zhang et al. International Journal of Nanomedicine
- Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity
- (2010) Kui Yang et al. BMC CANCER
- Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance
- (2010) Lisa J Harper et al. BMC CANCER
- Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
- (2010) J Hao et al. BRITISH JOURNAL OF CANCER
- CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer
- (2010) M. C. de Jong et al. CLINICAL CANCER RESEARCH
- CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
- (2010) J.L. Hao et al. CURRENT CANCER DRUG TARGETS
- Impact of Genomic Methylation on Radiation Sensitivity of Colorectal Carcinoma
- (2010) Barbara Hofstetter et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long-Term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?
- (2010) Deborah A. Kuban et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer
- (2010) Jen-Tsun Lin et al. ORAL ONCOLOGY
- Cancer stem cells: Back to Darwin?
- (2010) Mel Greaves SEMINARS IN CANCER BIOLOGY
- Use of γH2AX and Other Biomarkers of Double-Strand Breaks During Radiotherapy
- (2010) Ali Sak et al. SEMINARS IN RADIATION ONCOLOGY
- Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression
- (2009) H Chen et al. BRITISH JOURNAL OF CANCER
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Moderate Dose Escalation in Three-Dimensional Conformal Localized Prostate Cancer Radiotherapy
- (2009) Gregor Goldner et al. STRAHLENTHERAPIE UND ONKOLOGIE
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
- (2008) E M Hurt et al. BRITISH JOURNAL OF CANCER
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53
- (2008) S. Supiot et al. MOLECULAR CANCER THERAPEUTICS
- Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
- (2008) David Naor et al. SEMINARS IN CANCER BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search